Annual CFF
$356.04M$2.52B+116.47%
Summary
- Current Value
- As of today, RPRX annual cash from financing is $356.04M, up +116.47% on
- Historical Performance
- RPRX annual cash from financing is up +4.44% over the past 3 years, and up +129.88% over the past 5 years
- All-Time High Comparison
- RPRX annual cash from financing is currently -74.92% below its historical high of $1.42B set on
- 3-Year Low Comparison
- RPRX annual cash from financing is +116.47% above its 3-year low of -$2.16B reached on
- Sector Comparison
- RPRX annual cash from financing is higher than 94.91% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $356.04M | +116.5% | +4.4% | +129.9% | +5377.8% | |
| Quarterly Cash From Financing | $562.94M | +272.3% | +342.7% | +274.7% | +278.7% | |
| TTM Cash From Financing | -$1.15B | -405.2% | -26.6% | -177.9% | -265.6% | |
| Price | $39.72 | +29.2% | +0.9% | -23.5% | – | |
| Annual Cash From Operations | $2.79B | -7.9% | +38.4% | +67.5% | +113.9% | |
| Annual Cash From Investing | -$2.70B | -28.1% | -47.6% | -27.4% | -4294.7% | |
| Annual Dividends Paid | $376.47M | +5.1% | +32.0% | -49.1% | +100.0% | |
| Annual Total Debt | $7.61B | +24.1% | +7.3% | +22.0% | +27.1% | |
| Shares Outstanding | 427.25M | -4.2% | -3.6% | +10.1% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $356.04M | at high | |
| 5Y | $1.42B | N/A | -74.9% |
| All | $1.42B | -74.9% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$2.16B | +116.5% | |
| 5Y | -$2.16B | +116.5% | |
| All | -$2.16B | +116.5% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| $356.04M | +116.5% | |
| -$2.16B | -127.0% | |
| -$952.05M | -379.3% | |
| $340.90M | -76.0% | |
| $1.42B | +219.1% |
| Year | Value | Change |
|---|---|---|
| -$1.19B | +13.6% | |
| -$1.38B | -1,018.9% | |
| -$123.25M | +86.7% | |
| -$923.32M | >-9,900.0% | |
| -$6.75M | - |
FAQ
What is the current annual cash from financing of RPRX?
As of today, RPRX annual cash from financing is $356.04M
What is 1-year change in RPRX annual cash from financing?
RPRX annual cash from financing is up +116.47% year-over-year
What is 3-year change in RPRX annual cash from financing?
RPRX annual cash from financing is up +4.44% over the past 3 years
How far is RPRX annual cash from financing from its all-time high?
RPRX annual cash from financing is currently -74.92% below its historical high of $1.42B set on December 31, 2020
How does RPRX annual cash from financing rank versus sector peers?
RPRX annual cash from financing is higher than 94.91% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly CFF
$562.94M$1.08B+209.81%
Summary
- Current Value
- As of today, RPRX quarterly cash from financing is $562.94M, up +209.81% on
- Historical Performance
- RPRX quarterly cash from financing is up +272.28% year-over-year, and up +342.70% over the past 3 years
- All-Time High Comparison
- RPRX quarterly cash from financing is currently -64.27% below its historical high of $1.58B set on
- 3-Year Low Comparison
- RPRX quarterly cash from financing is +141.35% above its 3-year low of -$1.36B reached on
- Sector Comparison
- RPRX quarterly cash from financing is higher than 99.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | $562.94M | +209.8% | +272.3% | +342.7% | +274.7% | |
| Annual Cash From Financing | $356.04M | – | +116.5% | +4.4% | +129.9% | |
| TTM Cash From Financing | -$1.15B | +43.6% | -405.2% | -26.6% | -177.9% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| Quarterly Cash From Operations | $703.52M | +64.8% | -1.6% | +30.6% | +38.3% | |
| Quarterly Cash From Investing | -$959.42M | -159.2% | +20.2% | +32.6% | +7.7% | |
| Quarterly Dividends Paid | $95.31M | +2.2% | +1.3% | +13.7% | +73.7% | |
| Quarterly Total Debt | $8.96B | +11.8% | +17.8% | +26.0% | +54.2% | |
| Shares Outstanding | 427.25M | – | -4.2% | -3.6% | +10.1% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $562.94M | at high | |
| 3Y | $1.16B | -51.3% | |
| 5Y | $1.16B | -51.3% | |
| All | $1.58B | -64.3% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$942.60M | +159.7% | |
| 3Y | -$1.36B | +141.3% | |
| 5Y | -$1.36B | +141.3% | |
| All | -$1.36B | +141.3% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of RPRX?
As of today, RPRX quarterly cash from financing is $562.94M
What is RPRX quarterly cash from financing most recent change?
RPRX quarterly cash from financing was up +209.81% on September 30, 2025
What is 1-year change in RPRX quarterly cash from financing?
RPRX quarterly cash from financing is up +272.28% year-over-year
How far is RPRX quarterly cash from financing from its all-time high?
RPRX quarterly cash from financing is currently -64.27% below its historical high of $1.58B set on June 30, 2020
How does RPRX quarterly cash from financing rank versus sector peers?
RPRX quarterly cash from financing is higher than 99.00% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM CFF
-$1.15B$889.70M+43.59%
Summary
- Current Value
- As of today, RPRX TTM cash from financing is -$1.15B, up +43.59% on
- Historical Performance
- RPRX TTM cash from financing is down -405.21% year-over-year, and down -26.56% over the past 3 years
- All-Time High Comparison
- RPRX TTM cash from financing is currently -175.74% below its historical high of $1.52B set on
- 3-Year Low Comparison
- RPRX TTM cash from financing is +47.42% above its 3-year low of -$2.19B reached on
- Sector Comparison
- RPRX TTM cash from financing is higher than 3.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$1.15B | +43.6% | -405.2% | -26.6% | -177.9% | |
| Annual Cash From Financing | $356.04M | – | +116.5% | +4.4% | +129.9% | |
| Quarterly Cash From Financing | $562.94M | +209.8% | +272.3% | +342.7% | +274.7% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| TTM Cash From Operations | $2.51B | -0.5% | -11.2% | +21.5% | +27.8% | |
| TTM Cash From Investing | -$1.37B | +15.1% | +57.1% | +30.3% | +30.4% | |
| TTM Dividends Paid | $377.57M | +0.3% | +1.5% | +17.0% | -26.8% | |
| Quarterly Total Debt | $8.96B | +11.8% | +17.8% | +26.0% | +54.2% | |
| Shares Outstanding | 427.25M | – | -4.2% | -3.6% | +10.1% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $356.04M | N/A | -423.4% |
| 3Y | $377.28M | -405.2% | |
| 5Y | $1.42B | N/A | -181.1% |
| All | $1.52B | -175.7% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.04B | +43.6% | |
| 3Y | -$2.19B | +47.4% | |
| 5Y | -$2.19B | +47.4% | |
| All | -$2.19B | +47.4% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of RPRX?
As of today, RPRX TTM cash from financing is -$1.15B
What is RPRX TTM cash from financing most recent change?
RPRX TTM cash from financing was up +43.59% on September 30, 2025
What is 1-year change in RPRX TTM cash from financing?
RPRX TTM cash from financing is down -405.21% year-over-year
How far is RPRX TTM cash from financing from its all-time high?
RPRX TTM cash from financing is currently -175.74% below its historical high of $1.52B set on June 30, 2020
How does RPRX TTM cash from financing rank versus sector peers?
RPRX TTM cash from financing is higher than 3.90% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx